Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 3 |
Descriptor
Cancer | 3 |
Policy Formation | 3 |
Screening Tests | 3 |
Evidence | 2 |
Foreign Countries | 2 |
Alaska Natives | 1 |
At Risk Persons | 1 |
Barriers | 1 |
Case Studies | 1 |
Comparative Analysis | 1 |
Comparative Education | 1 |
More ▼ |
Author
Publication Type
Journal Articles | 3 |
Reports - Research | 2 |
Reports - Evaluative | 1 |
Education Level
Audience
Location
Australia | 2 |
New Zealand | 2 |
United Kingdom | 2 |
Alaska | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Redwood, Diana; Provost, Ellen; Lopez, Ellen D. S.; Skewes, Monica; Johnson, Rhonda; Christensen, Claudia; Sacco, Frank; Haverkamp, Donald – Health Education & Behavior, 2016
This article presents the results of a process evaluation of the Alaska Native (AN) Colorectal Cancer (CRC) Family Outreach Program, which encourages CRC screening among AN first-degree relatives (i.e., parents, siblings, adult children; hereafter referred to as relatives) of CRC patients. Among AN people incidence and death rates from CRC are the…
Descriptors: Alaska Natives, Cancer, Outreach Programs, Screening Tests
Flitcroft, Kathy; Gillespie, James; Carter, Stacy; Salkeld, Glenn; Trevena, Lyndal – Evidence & Policy: A Journal of Research, Debate and Practice, 2014
Much of the evidence translation literature focuses narrowly on the use of evidence in the initial policy formulation stages, and downplays the crucial role of institutions and the inherently political nature of policy making. More recent approaches acknowledge the importance of institutional and political factors, but make no attempt to…
Descriptors: Public Health, Public Policy, Evidence Based Practice, Political Influences
Flitcroft, Kathy L.; Gillespie, James A.; Carter, Stacy M.; Trevena, Lyndal J.; Salkeld, Glenn P. – Evidence & Policy: A Journal of Research, Debate and Practice, 2011
Bowel cancer is a serious health problem in developed countries. Australia, the United Kingdom (UK) and New Zealand (NZ) reviewed the same randomised controlled trial evidence on the benefits and harms of population-based bowel cancer screening. Yet only NZ, with the highest age standardised rate of bowel cancer mortality, decided against…
Descriptors: Cancer, Screening Tests, Foreign Countries, Randomized Controlled Trials